摘要
本文报告了小牛胸腺肽(CTP)治疗乙肝患者50例(慢迁肝23例,慢活肝16例,重症肝炎11例)和HBsAg携带者10例的结果,CTP对消除或减轻临床症状和体征,改善肝功能具有明显的疗效,对慢迁肝,慢活肝和重症肝炎的治疗效果基本相同,各组间无显著性差异。对HBV血清学指标无重要改变,对HBsAg携带者疗效不侍。并对剂景、疗程与疗效的关系进行了讨论。
Cow thymus peptide ( CTP ) was used to cure 23 chronic persistent HB cases,16 chronic active cases, 11 grave cases and 10 HBsAg carriers, The results showed that CTP could eliminate or alleviate clinical symptoms and signs, improveiverl functions and have the curative effect on various types of HB. However,HBV serum markers had not been changed in all of the cases and little effect was found in the treatment of HBsAgcarriers. The relationships among dosage, course of treatment and effect were also disscussed.
出处
《西南国防医药》
CAS
1992年第3期134-136,191,共4页
Medical Journal of National Defending Forces in Southwest China
